Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-27 4:29 pm Sale | 13D | NUCANA PLC SPONSORED ADR NCNA | Sofinnova Venture Partners VIII L.P. | 6,283,392 11.900% | -1,797,869 (-22.25%) | View |
| 2023-02-03 7:26 pm Unchanged | 13D | OBSEVA SA COM OBSVF | Sofinnova Venture Partners VIII L.P. | 4,749,623 4.700% | 0 (Unchanged) | View |
| 2022-02-25 7:39 pm Sale | 13D | OBSEVA SA COM OBSVF | Sofinnova Venture Partners VIII L.P. | 4,749,623 6.100% | -96,006 (-1.98%) | View |
| 2022-02-25 7:34 pm Purchase | 13D | NUCANA PLC SPONSORED ADR NCNA | Sofinnova Venture Partners VIII L.P. | 8,081,261 15.500% | 35,512 (+0.44%) | View |
| 2021-03-04 06:13 am Purchase | 13D | OBSEVA SA COM OBSVF | Sofinnova Venture Partners VIII L.P. | 4,845,629 8.800% | 37,143 (+0.77%) | View |
| 2020-10-02 8:58 pm Purchase | 13D | NUCANA PLC SPONSORED ADR NCNA | Sofinnova Venture Partners VIII L.P. | 8,045,749 16.600% | 3,333,333 (+70.74%) | View |
| 2020-02-13 1:38 pm Purchase | 13D | OBSEVA SA COM OBSVF | Sofinnova Venture Partners VIII L.P. | 4,808,486 11.000% | 50,530 (+1.06%) | View |
| 2020-02-13 1:31 pm Purchase | 13D | Natera Inc. NTRA | Sofinnova Venture Partners VIII L.P. | 3,141,345 4.100% | 18,447 (+0.59%) | View |
| 2020-02-13 1:22 pm Sale | 13G | Principia Biopharma Inc. PRNB | Sofinnova Venture Partners VIII L.P. | 1,438,196 4.400% | -620,950 (-30.16%) | View |